BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3586502)

  • 21. Norepinephrine-related mechanism in hypertension accompanying renal failure.
    Schohn D; Weidmann P; Jahn H; Beretta-Piccoli C
    Kidney Int; 1985 Nov; 28(5):814-22. PubMed ID: 4087696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.
    Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
    Kidney Int; 1985 Oct; 28(4):658-65. PubMed ID: 3910913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased vascular sensitivity to angiotensin ii in psychosocial hypertensive mice.
    Webb RC; Johnson JC; Vander AJ; Henry JP
    Hypertension; 1983; 5(2 Pt 2):I165-9. PubMed ID: 6826225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension.
    Widgren BR; Herlitz H; Aurell M; Berglund G; Wikstrand J; Andersson OK
    Am J Hypertens; 1992 Mar; 5(3):167-74. PubMed ID: 1575943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma aldosterone response to angiotensin II in sodium-restricted elderly subjects with essential hypertension.
    Morimoto S; Uchida K; Miyamoto M; Kigoshi T; Morise T; Takimoto H; Takeda R
    J Am Geriatr Soc; 1981 Jul; 29(7):302-7. PubMed ID: 7016959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Hypertension; 1983; 5(3):368-74. PubMed ID: 6341220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of diltiazem hydrochloride on pressor and steroidogenic actions of angiotensins and norepinephrine in man.
    Ikeda F; Kono T; Oseko F; Imura H; Endo J
    Endocrinol Jpn; 1980 Dec; 27(6):779-84. PubMed ID: 7262036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pressor factors and cardiovascular pressor responsiveness in borderline hypertension.
    Meier A; Weidmann P; Grimm M; Keusch G; Glück Z; Minder I; Ziegler WH
    Hypertension; 1981; 3(3):367-72. PubMed ID: 7019068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.
    Uehlinger DE; Weidmann P; Gnaedinger MP; Shaw S; Lang RE
    J Clin Endocrinol Metab; 1986 Sep; 63(3):669-74. PubMed ID: 2942555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of high calcium intake on pressor responsivity in hypertensive rats.
    Stern N; Golub M; Nyby M; Berger M; Eggena P; Lee DB; Tuck ML; Brickman AS
    Am J Physiol; 1987 Jun; 252(6 Pt 2):H1112-9. PubMed ID: 3296787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered pressor responses in long-term nitrendipine treatment.
    Simon G; Snyder DK
    Clin Pharmacol Ther; 1984 Sep; 36(3):315-9. PubMed ID: 6380880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic modulation of pressor and hormonal responses in essential hypertension.
    Sowers JR; Golub MS; Berger ME; Whitfield LA
    Hypertension; 1982; 4(3):424-30. PubMed ID: 6279498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular pressor reactivity after chronic converting enzyme inhibition.
    Bernasconi M; Marone C; Beretta-Piccoli C; Lepori G; Shaw S; Weidmann P
    Am J Hypertens; 1991 Apr; 4(4 Pt 1):348-55. PubMed ID: 1829371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertensive dysregulation and its modification by calcium channel blockade in nonoliguric renal failure.
    Weidmann P; Schohn D; Gnädinger MP; Bürgisser E; Ferrier C; Jahn H
    Am J Nephrol; 1989; 9(4):269-78. PubMed ID: 2683789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension.
    Weidmann P; Beretta-Piccoli C; Link L; Bianchetti MG; Boehringer K; Morton JJ
    Hypertension; 1983; 5(6):873-80. PubMed ID: 6360870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular and metabolic profile during intervention with urapidil in humans.
    Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
    Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of short-term norepinephrine infusion on plasma catecholamines, renin, and aldosterone in normal and hypertensive man.
    Beretta-Piccoli C; Weidmann P; Meier A; Grimm M; Keusch G; Glück Z
    Hypertension; 1980; 2(5):623-30. PubMed ID: 6998868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenetic and therapeutic relevance of cardiovascular pressor reactivity to norepinephrine in human hypertension.
    Weidmann P
    Clin Exp Hypertens A; 1989; 11 Suppl 1():257-73. PubMed ID: 2663249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic, renal, and hormonal responses to changes in dietary potassium in normotensive and hypertensive man: long-term antihypertensive effect of potassium supplementation in essential hypertension.
    Overlack A; Stumpe KO; Moch B; Ollig A; Kleinmann R; Müller HM; Kolloch R; Krück F
    Klin Wochenschr; 1985 Apr; 63(8):352-60. PubMed ID: 3923252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular pressor responses in treated and untreated essential hypertension.
    Donnelly R; Elliott HL; Howie CA; Sumner DJ; Reid JL
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):191-6. PubMed ID: 1697373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.